Skip to content
Drug recall · FDA · Published April 20, 2020

Lupin Pharmaceuticals Inc. recalls Lisinopril Tablets USP, 20 mg, 1000-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore MD

Lupin Pharmaceuticals recalls 20mg Lisinopril tablets due to potential mix-up with 10mg tablets in sealed bottles. Affected products have NDC 68180-0981-03 and lot # Q000255.

🇺🇸 FDA recall #D-1250-2020DrugLupin Pharmaceuticals ›
Take action

Contact the company & request your remedy

Recalling firmLupin Pharmaceuticals Inc.Harborplace Tower, 111 S Calvert St Fl 21st · Baltimore, MD 21202-6174
No email on file for this recall — reach the company by phone or its official page instead.No email on file — write to the address above instead.
✎ GovInfoNow plain-language explainer

What happened, in plain English

Lupin Pharmaceuticals is recalling 20mg Lisinopril tablets that may contain 10mg tablets due to a mix-up in sealed bottles. This could lead to incorrect dosing if taken without proper medical supervision. Read more at govinfonow.com/recall/37137-lupin-lisinopril-20mg-tablets-recall-mix-up-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/37137-lupin-lisinopril-20mg-tablets-recall-mix-up-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-1250-2020

Cite this page

“Lupin Lisinopril 20mg Tablets Recall: Mix-up Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37137-lupin-lisinopril-20mg-tablets-recall-mix-up-risk. Based on FDA recall #D-1250-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1250-2020%22&limit=1).

Why it’s dangerous

The mix-up involves 10mg tablets being mistakenly placed inside sealed bottles labeled as 20mg. If taken without medical supervision, this could cause incorrect dosing. The risk is low because the product is prescription-only and the mix-up is limited to specific bottles.

Who’s affected

People with prescriptions for Lisinopril 20mg tablets who received this specific product. Those with diabetes or kidney issues may be at higher risk due to dosage errors.

How to tell if you have this one

Check for NDC code 68180-0981-03 and lot number Q000255 on the bottle. The product is a 1000-count bottle of 20mg Lisinopril tablets, Rx only, manufactured in Baltimore, MD.

  • Brand
    Lupin Pharmaceuticals
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for NDC 68180-0981-03 and lot number Q000255 on the bottle label.

✎ GovInfoNow

Questions people ask

Is this product safe to use?

The product may contain 10mg tablets instead of 20mg due to a mix-up. It is prescription-only and should be checked for the correct dosage.

How can I tell if I have the recalled product?

Check for NDC code 68180-0981-03 and lot number Q000255 on the bottle label. The product is a 1000-count bottle of 20mg Lisinopril tablets, Rx only.

What should I do if I have the recalled product?

The recall does not specify a remedy. Check the product details and contact your doctor or pharmacist for guidance.

Take action

Contact Lupin Pharmaceuticals

We’ve drafted a message you can send Lupin Pharmaceuticals to request your refund or repair — edit it as you like.

Subject: Recall D-1250-2020 — Lupin Pharmaceuticals Lupin Pharmaceuticals

Hello,

I own a Lupin Pharmaceuticals that is covered by recall D-1250-2020 from Lupin Pharmaceuticals.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

Keep exploring

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Comments are reviewed before they appear. No links, ads, or personal attacks — those get removed.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1250-2020 (April 20, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1250-2020 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA